Mobile Health-based Motivational Interviewing for Vaccine Hesitancy
(COVID-19 Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
The trial aims to evaluate how effectively a new mobile health app, MOTIVACC, encourages COVID-19 vaccination compared to traditional phone calls. It uses motivational interviewing, a conversational technique that helps individuals decide to make beneficial health changes. The trial includes three groups, each testing a different method of motivational interviewing. It is suitable for English speakers in rural areas who have not yet received any COVID-19 vaccine shots and can use a smartphone. As an unphased trial, this study provides a unique opportunity to contribute to innovative research that could enhance public health strategies.
What prior data suggests that this mobile Health-based motivational interviewing intervention is safe?
Research has shown that motivational interviewing (MI) methods, such as the MOTIVACC approach, are generally easy for people to handle. Studies have found these methods to be safe and effective in reducing vaccine-related worries, helping individuals feel more comfortable with vaccination without causing harm.
The trial does not involve taking new medicine or undergoing a medical procedure, so safety concerns are minimal. Instead, it focuses on communication strategies using mobile health technology. This method has been successfully applied in other areas, with no major safety issues reported.
In summary, the MOTIVACC treatment is considered safe. It aids individuals in making informed vaccination decisions through conversation, not by taking new medicines.12345Why are researchers excited about this trial?
Researchers are excited about this trial because it explores how motivational interviewing (MI), delivered via mobile technology, can address vaccine hesitancy. Unlike traditional methods that rely on in-person conversations, this approach uses a digital platform, making it more accessible and scalable. The trial examines two variations: Intensive MI and Standard MI, alongside the MOTIVACC approach, to determine the most effective method for encouraging vaccination. By potentially increasing vaccine uptake through personalized, convenient communication, this trial could pave the way for innovative public health strategies.
What evidence suggests that this trial's treatments could be effective for vaccine hesitancy?
Research has shown that motivational interviewing (MI) can help reduce doubts about vaccines. Some studies have found that people are more likely to plan on getting vaccinated after MI. In this trial, participants will experience different approaches, including Intensive MI, Standard MI, and the MOTIVACC app, a Mobile Health-based MI. The MOTIVACC app reaches people more easily through their phones. Early results suggest this approach might work well, especially in rural areas. It offers a promising way to increase vaccine uptake by directly addressing people's concerns.12346
Are You a Good Fit for This Trial?
This trial is for adults over 18 living in rural areas who haven't had a COVID-19 vaccine and can speak English. They must be able to consent and use a smartphone. It's not for those with certain medical/psychiatric conditions, involved in other COVID studies, or pregnant/lactating women.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Participants receive mobile Health-based motivational interviewing (MI) intervention to promote SARS-CoV-2 vaccination
Follow-up
Participants are monitored for vaccination uptake and intervention effectiveness
What Are the Treatments Tested in This Trial?
Interventions
- MOTIVACC
Find a Clinic Near You
Who Is Running the Clinical Trial?
Oklahoma State University
Lead Sponsor
University of Oklahoma
Collaborator